Lv4
420 积分 2024-09-27 加入
Clinical strategies with antibody–drug conjugates as potential modifications for virotherapy
6天前
已完结
Rational combinations of targeted cancer therapies: background, advances and challenges
22天前
已完结
Development of ICT01, a first-in-class, anti-BTN3A antibody for activating Vγ9Vδ2 T cell–mediated antitumor immune response
1个月前
已完结
CDC7 as a novel biomarker and druggable target in cancer
1个月前
已完结
CDC7-independent G1/S transition revealed by targeted protein degradation
1个月前
已完结
CDK12 inhibition enhances sensitivity of HER2+ breast cancers to HER2-tyrosine kinase inhibitor via suppressing PI3K/AKT
1个月前
已完结
γδ T cell effector functions: a blend of innate programming and acquired plasticity
1个月前
已完结
Relevance of AKT and RAS Signaling Pathways for Antibody–Drug Conjugate Immunotherapies in Acute Lymphoblastic Leukemia
1个月前
已完结
A Bispecific γδ T-cell Engager Targeting EGFR Activates a Potent Vγ9Vδ2 T cell–Mediated Immune Response against EGFR-Expressing Tumors
1个月前
已完结
Receptor CDCP1 Is a Potential Target for Personalized Imaging and Treatment of Poor Outcome HER2+, Triple-Negative, and Metastatic ER+/HER2− Breast Cancers
2个月前
已完结
皖公网安备34019202002308
